Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...
Credit: Lilly. The 4-dose KwikPen device supports weight reduction in patients with obesity or overweight with weight-related conditions. The device is for single-patient use only and should never be ...
The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device. Lilly says the new pen expands patient choice, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results